Kathryn Dahir is an Endocrinology/Metabolic physician affiliated with Vanderbilt University. OpenAlex indexes 102 publications with 1,456 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 Tvc
Nashville, TN 372320001
Telephone
615-322-3000Provider last certified this registry record 29 Mar 2022.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year202521 payments$23,809openpaymentsdata.cms.gov ↗
- Novo Nordisk Health Care AGProgram year20256 payments$10,599openpaymentsdata.cms.gov ↗
- Kyowa Kirin Services LtdProgram year20254 payments$10,050openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
63%Parathyroid Hormone-Related Peptide Analog23.6%Tymlos100%Part D≥22 patientsl-Thyroxine20.2%Levothyroxine Sodium70%Synthroid30%Part D≥27 patients+ 2 more classes in this area
Metabolism & gastrointestinal
27.8%Tissue-nonspecific Alkaline Phosphatase23.6%Strensiq100%Part D≥12 patientsVitamin D3 Analog4.2%Calcitriol100%Part D<11 patientsMusculoskeletal
7.1%Other drugs affecting bone structure and mineralization7.1%Crysvita100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Medical Management of Hypophosphatasia: Review of Data on Asfotase Alfa
Current Osteoporosis Reports
2025 - The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data
Orphanet Journal of Rare Diseases
2025 - Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study
Journal of Bone and Mineral Research
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Crowe, MD
Vanderbilt University
Ingrid Mayer, MD
Vanderbilt University
Michael Debaun, MD
Vanderbilt University
Sam Chang, MD
Vanderbilt University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”